IP is the key driver of innovation. It has enabled unprecedented collaborations between biopharmaceutical innovators and governments, universities and other research partners to speed up progress on hundreds of potential COVID-19 treatments, diagnostics and vaccines for patients. It is only because of intellectual property protection that we have over 30o treatments and more than 200 vaccines currently being explored for use against COVID-19.
© [2020] 3 Eyes imperial
Help
Track Order
Delivery & Returns
About Us
Careers
Corporate Responsibility